ICD-10 Coding for Evoked Otoacoustic Emissions(H90.0, H90.0M, H90.3)
Learn about the ICD-10 coding and documentation requirements for evoked otoacoustic emissions, including key codes, documentation templates, and common pitfalls.
Complete code families applicable to Evoked Otoacoustic Emissions
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| H91.23 | Auditory neuropathy | Use when auditory neuropathy is diagnosed, characterized by normal otoacoustic emissions but abnormal auditory brainstem response. |
|
| H93.25 | Cochlear conductive hearing loss | Use when cochlear conductive hearing loss is diagnosed, characterized by absent otoacoustic emissions at specific frequencies. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutEvoked Otoacoustic Emissions
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Evoked Otoacoustic Emissions.
Using 'pass/fail' terminology
Impact
Clinical: Lacks specificity needed for clinical decision-making., Regulatory: Fails to meet documentation standards., Financial: May lead to claim denials.
Mitigation
Use detailed frequency-specific results, Provide interpretation of findings
Using screening codes for diagnostic purposes
Impact
Reimbursement: Claims may be denied if screening codes are used incorrectly., Compliance: Incorrect coding can lead to compliance issues during audits., Data Quality: Misclassification affects data accuracy and patient records.
Mitigation
Use diagnostic codes such as 92587 or 92588 for detailed evaluations.
Overuse of screening codes
Impact
Frequent use of screening codes for diagnostic purposes can trigger audits.
Mitigation
Ensure proper use of diagnostic codes with supporting documentation.